SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guidant (GDT)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JMS who wrote (53)11/28/1997 10:35:00 PM
From: B4TheBell  Read Replies (1) of 235
 
JMS,

Your comments prompted a little search on GDT. Found these items on Reuters...

CHICAGO, Nov 25 (Reuters) - J.P. Morgan Securities Inc said Tuesday it raised fourth quarter earnings estimates for Guidant Corp based on "booming" coronary stent sales.

Analyst Michael Weinstein raised his fourth quarter earnings estimate to $0.48 a share from $0.38.

He estimated stent sales of $100 million in the fourth quarter, which includes $80 million in U.S. sales (up from a previous estimate of $40 million). The balance will be generated in markets outside the U.S.

Shares of Guidant were trading up 13/16 to 63-3/4. 11:35 11-25-97
*****************************************
Block trade - Guidant (GDT) 100,000 at 64-1/2, crossed by Smith Barney REUTERS 12:43 11-26-97

Block trade - Guidant (GDT) 100,000 at 64-5/8, crossed by Smith Barney REUTERS 12:50 11-26-97

Block trade - Guidant (GDT) 100,000 at 64-1/2, crossed by Smith Barney REUTERS 09:53 11-28-97
*****************************************
You're right. I don't think GDT should have any trouble breaking 65 soon. Maybe we should wait 'til strikes at 70 are issued...

BTW, I have 4Qtr97 and FY97 earnings due 1st week in February...

B4
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext